☆ 4.7 Article

Myeloid-derived suppressor cells (MDSCs) depletion by cabozantinib improves the efficacy of anti-HER2 antibody-based immunotherapy in a 4T1-HER2 murine breast cancer model

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

Get Full Text
Add to Collection

Journal

INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 113, Issue -, Pages 109470

Publisher

Elsevier BV
DOI: 10.1016/j.intimp.2022.109470

Keywords

-

Categories

Immunology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.